Broad Immunogenicity of a Multigene, Multiclade HIV‐1 DNA Vaccine Boosted with Heterologous HIV‐1 Recombinant Modified Vaccinia Virus Ankara-Reference-Cited by-同舟云学术

Broad Immunogenicity of a Multigene, Multiclade HIV‐1 DNA Vaccine Boosted with Heterologous HIV‐1 Recombinant Modified Vaccinia Virus Ankara

Published:2008-11-15 Issue:10 Volume:198 Page:1482-1490
ISSN:0022-1899
Container-title:The Journal of Infectious Diseases
language:en
Short-container-title:J INFECT DIS

Author:

Sandström Eric,Nilsson Charlotta,Hejdeman Bo,Bråve Andreas,Bratt Göran,Robb Merlin,Cox Josephine,VanCott Thomas,Marovich Mary,Stout Richard,Aboud Said,Bakari Muhammad,Pallangyo Kisali,Ljungberg Karl,Moss Bernard,Earl Patricia,Michael Nelson,Birx Deborah,Mhalu Fred,Wahren Britta,Biberfeld Gunnel,

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Immunology and Allergy

Link

http://academic.oup.com/jid/article-pdf/198/10/1482/18053496/198-10-1482.pdf

Reference34 articles.

1. Joint United Nations Programme on HIV/AIDS (UNAIDS). AIDS Epidemic Update: December 2006. Available at: http://www.unaids.org/en/HIV_data/epi2006. Accessed 8 September 2008.

2. An HIV Vaccine — Evolving Concepts

3. Inhibition of HIV-1 entry by antibodies: potential viral and cellular targets

4. Correlation between Immunologic Responses to a Recombinant Glycoprotein 120 Vaccine and Incidence of HIV‐1 Infection in a Phase 3 HIV‐1 Preventive Vaccine Trial

5. T cell vaccines for microbial infections

Cited by 128 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Results of Clinical Trials of Recombinant Vaccine Virus, MVA Strain, Expressing Genes of Human Immunodeficiency Virus;Problems of Particularly Dangerous Infections;2021-10-23

2. Reciprocal Inhibition of Immunogenic Performance in Mice of Two Potent DNA Immunogens Targeting HCV-Related Liver Cancer;Microorganisms;2021-05-17

3. Mice Immunized with the Vaccine Candidate HexaPro Spike Produce Neutralizing Antibodies against SARS-CoV-2;Vaccines;2021-05-12

4. Mice immunized with the vaccine candidate HexaPro spike produce neutralizing antibodies against SARS-CoV-2;2021-03-01

5. Frequent Anti-V1V2 Responses Induced by HIV-DNA Followed by HIV-MVA with or without CN54rgp140/GLA-AF in Healthy African Volunteers;Microorganisms;2020-11-04